These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32032495)

  • 41. Questions Regarding the Value of CCL21 as a Potential Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis: Comment on the Article by Hoffmann-Vold et al.
    Zhou RP; Wei X; Ma GG; Zhu F; Chen FH; Hu W
    Arthritis Rheumatol; 2019 Apr; 71(4):653-654. PubMed ID: 30281217
    [No Abstract]   [Full Text] [Related]  

  • 42. Hit Early and Hit Hard in Pulmonary Arterial Hypertension? Not So Fast!
    Hassoun PM; Farber HW
    Am J Respir Crit Care Med; 2021 Oct; 204(7):755-756. PubMed ID: 34402772
    [No Abstract]   [Full Text] [Related]  

  • 43. Response by Mendes-Ferreira et al to Letter Regarding Article, "Bmpr2 Mutant Rats Develop Pulmonary and Cardiac Characteristics of Pulmonary Arterial Hypertension".
    Mendes-Ferreira P; Manaud G; Perros F
    Circulation; 2019 Aug; 140(7):e288-e289. PubMed ID: 31403844
    [No Abstract]   [Full Text] [Related]  

  • 44. Insufficient Evidence to Consider CCL21 a Potential Serum Biomarker for Pulmonary Arterial Hypertension in Systemic Sclerosis: Comment on the Article by Hoffmann-Vold et al.
    Xu WD; Su LC; Huang AF
    Arthritis Rheumatol; 2019 Apr; 71(4):654-655. PubMed ID: 30653848
    [No Abstract]   [Full Text] [Related]  

  • 45. Too hot? Too cold? Wnt signalling in pulmonary arterial hypertension: can we treat it "just right"?
    Goncharova EA; Kudryashova TV; Pullamsetti SS
    Eur Respir J; 2023 Jun; 61(6):. PubMed ID: 37290809
    [No Abstract]   [Full Text] [Related]  

  • 46. The updated cancer paradigm of PAH: recognizing complexity.
    Szulcek R; Grune J; Kuebler WM
    Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1111-L1114. PubMed ID: 32320264
    [No Abstract]   [Full Text] [Related]  

  • 47. Associations of Histamine Metabolites with Disease Severity and Mortality in Pulmonary Arterial Hypertension.
    Peplinski BS; Buber J; Gharib SA; Pi H; Raftery D; Leary PJ
    Ann Am Thorac Soc; 2023 Nov; 20(11):1676-1679. PubMed ID: 37668470
    [No Abstract]   [Full Text] [Related]  

  • 48. Regional Variation in Methamphetamine-associated Pulmonary Arterial Hypertension: Who'd Better Call Saul?
    Prohaska CC; Machado RF
    Ann Am Thorac Soc; 2021 Apr; 18(4):584-585. PubMed ID: 33792520
    [No Abstract]   [Full Text] [Related]  

  • 49. Performance of the ESC/ERS 4-strata risk stratification model for pulmonary arterial hypertension with missing variables.
    Pausch C; Pittrow D; Hoeper MM; Huscher D
    Eur Respir J; 2023 Nov; 62(5):. PubMed ID: 37802633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surrogate endpoints in pulmonary arterial hypertension trials.
    Hoeper MM
    Lancet Respir Med; 2023 Oct; 11(10):852-853. PubMed ID: 37230096
    [No Abstract]   [Full Text] [Related]  

  • 51. The role of genetics in pulmonary arterial hypertension associated with congenital heart disease.
    Cruz-Utrilla A; Gallego N; Segura de la Cal T; Tenorio-Castaño J; Arribas-Ynsaurriaga F; Escribano Subias P
    Rev Esp Cardiol (Engl Ed); 2021 Oct; 74(10):884-886. PubMed ID: 33972189
    [No Abstract]   [Full Text] [Related]  

  • 52. Determining the Architecture of Inflammation in Pulmonary Arterial Hypertension.
    Rajagopal S; Yu YR
    Am J Respir Crit Care Med; 2024 Jan; 209(2):131-133. PubMed ID: 38033319
    [No Abstract]   [Full Text] [Related]  

  • 53. [Current status and progress of research on pediatric pulmonary arterial hypertension].
    Qian YL; He JG
    Zhonghua Er Ke Za Zhi; 2024 Mar; 62(3):278-281. PubMed ID: 38378293
    [TBL] [Abstract][Full Text] [Related]  

  • 54. High altitude travelling with pulmonary arterial hypertension.
    Naeije R
    Eur Respir J; 2024 Mar; 63(3):. PubMed ID: 38453244
    [No Abstract]   [Full Text] [Related]  

  • 55. Reply to Hou et al.: Can Magnetic Resonance Imaging Effectively Evaluate the Prognosis of Patients with Pulmonary Arterial Hypertension?
    Swift AJ; Wild JM; Kiely DG
    Am J Respir Crit Care Med; 2018 Mar; 197(5):676-677. PubMed ID: 28961018
    [No Abstract]   [Full Text] [Related]  

  • 56. Finding Pulmonary Arterial Hypertension-Switching to Offense to Mitigate Disease Burden.
    Maron BA; Humbert M
    JAMA Cardiol; 2022 Apr; 7(4):369-370. PubMed ID: 35234810
    [No Abstract]   [Full Text] [Related]  

  • 57. circGSAP: A New Clinical Biomarker for Idiopathic Pulmonary Hypertension?
    Sun X; Chen R; Yao X; Zheng Z; Wang C; Chen J; Cheng J
    Am J Respir Crit Care Med; 2022 Jan; 205(2):252-253. PubMed ID: 34739355
    [No Abstract]   [Full Text] [Related]  

  • 58. Reply.
    Hoffmann-Vold AM; Didriksen H; Molberg Ø
    Arthritis Rheumatol; 2019 Apr; 71(4):655-656. PubMed ID: 30663863
    [No Abstract]   [Full Text] [Related]  

  • 59. Commentary: Respect idiopathic pulmonary hypertension…or urine trouble.
    Klapper JA
    J Thorac Cardiovasc Surg; 2022 Feb; 163(2):536-537. PubMed ID: 34175117
    [No Abstract]   [Full Text] [Related]  

  • 60. Reply to Bogaard
    Kojonazarov B; Hadzic S; Ghofrani HA; Grimminger F; Seeger W; Weissmann N; Schermuly RT
    Am J Respir Crit Care Med; 2019 Dec; 200(11):1450-1452. PubMed ID: 31437400
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.